Care of women with XY karyotype: a clinical practice guideline

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 105-113

  Jorgensen, Pernille Bach ^a   Kjartansdóttir, Kristín Rós ^a   Fedder, Jens ^a  

^a HORSENS REGIONAL HOSPITAL   (Denmark)

Author keywords

androgen insensitivity syndrome; androgen receptor; gonadal dysgenesis; infertility; malignancies; Morris syndrome; Swyer syndrome; XY females

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; FIBROBLAST GROWTH FACTOR 9; INHIBIN B; MUELLERIAN INHIBITING FACTOR; NUCLEAR RECEPTOR DAX 1; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR EMX2; TRANSCRIPTION FACTOR SOX9; WNT4 PROTEIN; WT1 PROTEIN;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL FEATURE; DELIVERY; DENMARK; DYSGERMINOMA; EVIDENCE BASED MEDICINE; GENE MUTATION; GONADAL DYSGENESIS; GONADECTOMY; HUMAN; INFERTILITY; KARYOTYPE 46,XY; PATHOGENESIS; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEMINOMA;

ANDROGEN-INSENSITIVITY SYNDROME; ANIMALS; FEMALE; GONADAL DYSGENESIS, 46,XY; HUMANS; INFERTILITY, FEMALE; KARYOTYPING; MALE; PATIENT CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 77952552533     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.087     Document Type: Article

References (101)

1. Morris J.M. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol 65 (1953) 1192-1211
2. Swyer G.I. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J 2 (1955) 709-712
3. Jost A., Vigier B., Prepin J., and Perchellet J.P. Studies on sex differentiation in mammals. Recent Prog Horm Res 29 (1973) 1-41
4. Fedder J., and Hjort T. Evidence for more than one male-specific antigen in the human. In: Boutaleb Y., and Gzouli A. (Eds). New concepts in reproduction. Recent developments in fertility and sterility series (1989), Parthenon Publishing Group, Carnforth, United Kingdom 117-120
5. Wachtel S.S. H-Y antigen and the biology of sex determination (1983), Grune & Stratton, New York
6. Hanley N.A., Ball S.G., Clement-Jones M., Hagan D.M., Strachan T., Lindsay S., et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev 87 (1999) 175-180
7. Kobayashi A., Shawlot W., Kania A., and Behringer R.R. Requirement of Lim1 for female reproductive tract development. Development 131 (2004) 539-549
8. Miyamoto N., Yoshida M., Kuratani S., Matsuo I., and Aizawa S. Defects of urogenital development in mice lacking Emx2. Development 124 (1997) 1653-1664
9. Ottolenghi C., Moreira-Filho C., Mendonca B.B., Barbieri M., Fellous M., Berkovitz G.D., et al. Absence of mutations involving the LIM homeobox domain gene LHX9 in 46,XY gonadal agenesis and dysgenesis. J Clin Endocrinol Metab 86 (2001) 2465-2469
10. Langman J.U. In: Langman J. (Ed). Medical embryology. 3rd ed (1975), Williams & Wilkins, Baltimore, MD 160-200 Chapter II; Urogenital System
11. Canto P., Vilchis F., Soderlund D., Reyes E., and Mendez J.P. A heterozygous mutation in the desert hedgehog gene in patients with mixed gonadal dysgenesis. Mol Hum Reprod 11 (2005) 833-836
12. DiNapoli L., Batchvarov J., and Capel B. FGF9 promotes survival of germ cells in the fetal testis. Development 133 (2006) 1519-1527
13. Katoh-Fukui Y., Tsuchiya R., Shiroishi T., Nakahara Y., Hashimoto N., Noguchi K., et al. Male-to-female sex reversal in M33 mutant mice. Nature 393 (1998) 688-692
14. Boyer A., Dornan S., Daneau I., Lussier J., and Silversides D.W. Conservation of the function of DMRT1 regulatory sequences in mammalian sex differentiation. Genesis 34 (2002) 236-243
15. Sekido R., and Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453 (2008) 930-934
16. Koopman P. Sry and Sox9: mammalian testis-determining genes. Cell Mol Life Sci 55 (1999) 839-856
17. Sinclair A.H., Berta P., Palmer M.S., Hawkins J.R., Griffiths B.L., Smith M.J., et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346 (1990) 240-244
18. Haqq C.M., King C.Y., Ukiyama E., Falsafi S., Haqq T.N., Donahoe P.K., et al. Molecular basis of mammalian sexual determination: activation of Mullerian inhibiting substance gene expression by SRY. Science 266 (1994) 1494-1500
19. Werner M.H., Huth J.R., Gronenborn A.M., and Clore G.M. Molecular basis of human 46X, Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81 (1995) 705-714
20. Jamin S.P., Arango N.A., Mishina Y., and Behringer R.R. Genetic studies of MIS signalling in sexual development. Novartis Found Symp 244 (2002) 157-164
21. Kellermayer R., Halvax L., Czako M., Shahid M., Dhillon V.S., Husain S.A., et al. A novel frame shift mutation in the HMG box of the SRY gene in a patient with complete 46,XY pure gonadal dysgenesis. Diagn Mol Pathol 14 (2005) 159-163
22. Hanley N.A., Hagan D.M., Clement-Jones M., Ball S.G., Strachan T., Salas-Cortes L., et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech Dev 91 (2000) 403-407
23. Vainio S., Heikkila M., Kispert A., Chin N., and McMahon A.P. Female development in mammals is regulated by Wnt-4 signalling. Nature 397 (1999) 405-409
24. Vilain E. Genetics of sexual development. Annu Rev Sex Res 11 (2000) 1-25
25. Parma P., Radi O., Vidal V., Chaboissier M.C., Dellambra E., Valentini S., et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 38 (2006) 1304-1309
26. Wilhelm D. R-spondin1-discovery of the long-missing, mammalian female-determining gene?. Bioessays 29 (2007) 314-318
27. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
28. Heinlein C.A., and Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 23 (2002) 175-200
29. Brinkmann A.O., Klaasen P., Kuiper G.G., van der Korput J.A., Bolt J., de Boer W., et al. Structure and function of the androgen receptor. Urol Res 17 (1989) 87-93
30. Tut T.G., Ghadessy F.J., Trifiro M.A., Pinsky L., and Yong E.L. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82 (1997) 3777-3782
31. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., and Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
32. Rajender S., Singh L., and Thangaraj K. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl 9 (2007) 147-179
33. Rajender S., Gupta N.J., Chakravarty B., Singh L., and Thangaraj K. Androgen insensitivity syndrome: do trinucleotide repeats in androgen receptor gene have any role?. Asian J Androl 10 (2008) 616-624
34. Gottlieb B., Beitel L.K., Wu J.H., and Trifiro M. The androgen receptor gene mutation database (ARDB): 2004 update. Hum Mutat 23 (2004) 527-533
35. McGill University. The androgen receptor gene mutations database World Wide Web server. Available at: http://androgendb.mcgill.ca. Last accessed February 2, 2009.
36. Hughes I.A., and Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab 20 (2006) 577-598
37. Adachi M., Takayanagi R., Tomura A., Imasaki K., Kato S., Goto K., et al. Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343 (2000) 856-862
38. Brinkmann A.O. Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179 (2001) 105-109
39. Boehmer A.L., Brinkmann O., Brüggenwirth H., van Assendelft C., Otten B.J., Verleun-Mooijman M.C., et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86 (2001) 4151-4160
40. Hawkins J.R., Taylor A., Goodfellow P.N., Migeon C.J., Smith K.D., and Berkovitz G.D. Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. Am J Hum Genet 51 (1992) 979-984
41. Lim H.N., Freestone S.H., Romero D., Kwok C., Hughes I.A., and Hawkins J.R. Candidate genes in complete and partial XY sex reversal: mutation analysis of SRY, SRY-related genes and FTZ-F1. Mol Cell Endocrinol 140 (1998) 51-58
42. McElreavey K., and Fellous M. Sex determination and the Y chromosome. Am J Med Genet 89 (1999) 176-185
43. Quintana-Murci L., and Fellous M. The human Y chromosome: the biological role of a "functional wasteland". J Biomed Biotechnol 1 (2001) 18-24
44. Preusser S., Diener P.A., l'Allemand-Jander D., Schmid S., Leippold T., Brandle M., et al. Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%). Urology 70 (2007) 1223-1229
45. Fedder J., Kristensen I.B., Friedrich U., and Agger A.O. [H-Y antigen and development of a testis in a girl with XY karyotype]. Ugeskr Laeger 151 (1989) 1060-1062
46. Robinson A., and Linden M.G. Ambiguous genitalia and hermaphroditism. Clinical genetic handbook. 2nd ed. (1993), Blackwell Scientific, Boston 309-15
47. Bangsboll S., Qvist I., Lebech P.E., and Lewinsky M. Testicular feminization syndrome and associated gonadal tumors in Denmark. Acta Obstet Gynecol Scand 71 (1992) 63-66
48. McPhaul M.J. Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 69 (1999) 315-322
49. McPhaul M.J. Androgen receptor mutations and androgen insensitivity. Mol Cell Endocrinol 198 (2002) 61-67
50. Reindollar RH, Tho SPT, McDonough PG. Delayed puberty development: an updated study of 326 patients. Trans Am Gynecol Obstet Soc 8:146-162.
51. Ogata T., and Matsuo N. Sex chromosome aberrations and stature: deduction of the principal factors involved in the determination of adult height. Hum Genet 91 (1993) 551-562
52. Varella J., Alvesalo L., and Vinkka H. Body size and shape in 46 XY females with complete testicular feminization. Ann Hum Biol 11 (1984) 291-301
53. Sobel V., Schwartz B., Zhu Y.S., Cordero J.J., and Imperato-McGinley J. Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. J Clin Endocrinol Metab 91 (2006) 3017-3023
54. Nora J.J., Torres F.G., Sinha A.K., and McNamara D.G. Characteristic cardiovascular anomalies of XO Turner syndrome, XX and XY phenotype and XO-XX Turner mosaic. Am J Cardiol 25 (1970) 639-641
55. Clarkson T.B. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 14 (2007) 373-384
56. Krum S.A., Miranda-Carboni G.A., Hauschka P.V., Carroll J.S., Lane T.F., Freedman L.P., et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 27 (2008) 535-545
57. Schindler A.E. Steroid metabolism in the gonads of a patient with testicular feminization. II. Metabolism of c19- and c18-steroids in vitro. Endokrinologie 67 (1976) 14-19
58. Hughes I.A., and Evans B.A.J. The fibroblast as a model for androgen resistant stages. Clin Endocrinol 28 (1988) 565-579
59. Krause A., Sinnecker G.H.G., Hjort O., Thamm B., and Hoepffner W. Applicability of the SHBG androgen sensitivity test in the differential diagnosis of 46,XY gonadal dysgenesis, true hermaphroditism, and androgen insensitivity syndrome. Exp Clin Endocrinol Diabetes 112 (2004) 236-240
60. Sinnescker G., and Kohler S. Sex hormone-binding globulin response to the anabolic steroid stanozolol: evidence for its suitability as a biological androgen sensitivity test. J Clin Endocrinol Metab 68 (1989) 1195-1200
61. Rey R.A., Belville C., Nihoul-Fekete C., Michel-Calemard L., Forest M.G., Lahlou N., et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab 84 (1999) 627-631
62. Davenport M., Brain C., Vandenberg C., Zappala S., Duffy P., Ransley P.G., et al. The use of the hCG stimulation test in the endocrine evaluation of cryptorchidism. Br J Urol 76 (1995) 790-794
63. Chen M.J., Yang J.H., Mao T.L., Ho H.N., and Yang Y.S. Successful pregnancy in a gonadectomized woman with 46,XY gonadal dysgenesis and gonadoblastoma. Fertil Steril 84 (2005) 217
64. Dirnfeld M., Bider D., Abramovicia H., Calderon I., and Blumenfeld Z. Subsequent successful pregnancy and delivery after intracytoplasmic sperm injection in a patient with XY gonadal dysgenesisms. Eur J Obstet Gynecol Reprod Biol 88 (2000) 101-102
65. Kan A.K., Abdalla H.I., and Oskarsson T. Two successful pregnancies in a 46,XY patient. Hum Reprod 12 (1997) 1434-1435
66. Selvaraj K., Ganesh V., and Selvaraj P. Successful pregnancy in a patient with a 46,XY karyotype. Fertil Steril 78 (2002) 419-420
67. Zielinska D., Zajaczek S., and Rzepka-Gorska I. Tumors of dysgenetic gonads in Swyer syndrome. J Pediatr Surg 42 (2007) 1721-1724
68. Duparc C., Boissiere-Veverka G., Lefebvre H., Laquerriere A., Vuillermet P., Landreat A., et al. An oestrogen-producing seminoma responsible for gynaecomastia. Horm Metab Res 35 (2003) 324-329
69. Gürer I., Demirkiran A.E., and Sare M. Sertoli cell tumor in two sibs with testicular feminization syndrome. Turk J Med Sci 30 (2000) 385-387
70. Sakai N., Yamada T., Asao T., Baba M., Yoshida M., and Murayama T. Bilateral testicular tumors in androgen insensitivity syndrome. Int J Urol 7 (2000) 390-392
71. American Cancer Society. Available at: http://www.cancer.org. Last accessed February 5, 2009.
72. Yager J.D., and Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36 (1996) 203-232
73. Zeng Q., Chen G.G., Vlantis A.C., and van Hasselt C.A. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 40 (2007) 921-935
74. Zeng Q., Chen G., Vlantis A., Tse G., and van Hasselt C. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 214 (2008) 425-433
75. Manuel M., Katayama P.K., and Jones Jr. H.W. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 124 (1976) 293-300
76. Cools M., Drop S.L., Wolffenbuttel K.P., Oosterhuis J.W., and Looijenga L.H. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 27 (2006) 468-484
77. Hannema S.E., Scott I.S., Rajpert-De Meyts E., Skakkebaek N.E., Coleman N., and Hughes I.A. Testicular development in the complete androgen insensitivity syndrome. J Pathol 208 (2006) 518-527
78. Troche V., and Hernandez E. Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv 41 (1986) 74-79
79. Gallager H.S., and Lewis R.P. Sequential gonadoblastoma and choriocarcinoma. Obstet Gynecol 41 (1973) 123-128
80. Schellhas H.F. Malignant potential of the dysgenetic gonad. Part 1. Obstet Gynecol 44 (1974) 298-309
81. Schellhas H.F. Malignant potential of the dysgenetic gonad. II. Obstet Gynecol 44 (1974) 455-462
82. Berg F.D., Kurzl R., Hinrichsen M.J., and Zander J. Familial 46,XY pure gonadal dysgenesis and gonadoblastoma/dysgerminoma: case report. Gynecol Oncol 32 (1989) 261-267
83. Michala L., Goswami D., Creighton S.M., and Conway G.S. Swyer syndrome: presentation and outcomes. BJOG 115 (2008) 737-741
84. Lau Y.F. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet 64 (1999) 921-927
85. Page D.C. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101 Suppl (1987) 151-155
86. Sultana R., Myerson D., and Disteche C.M. In situ hybridization analysis of the Y chromosome in gonadoblastoma. Genes Chromosomes Cancer 13 (1995) 257-262
87. Tsuchiya K., Reijo R., Page D.C., and Disteche C.M. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 57 (1995) 1400-1407
88. Uehara S., Funato T., Yaegashi N., Suziki H., Sato J., Sasaki T., et al. SRY mutation and tumor formation on the gonads of XP pure gonadal dysgenesis patients. Cancer Genet Cytogenet 113 (1999) 78-84
89. Warner B.A., Monsaert R.P., Stumpf P.G., Kulin H.E., and Wachtel S.S. 46,XY gonadal dysgenesis: is oncogenesis related to H-Y phenotype or breast development?. Hum Genet 69 (1985) 79-85
90. Gravholt C.H., Fedder J., Naeraa R.W., and Muller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 85 (2000) 3199-3202
91. Jurgensen M., Hiort O., Holterhus P.M., and Thyen U. Gender role behavior in children with XY karyotype and disorders of sex development. Horm Behav 51 (2007) 443-453
92. Johannsen T.H., Ripa C.P., Mortensen E.L., and Main K.M. Quality of life in 70 women with disorders of sex development. Eur J Endocrinol 155 (2006) 877-885
93. Migeon C.J., Wisniewski A.B., Brown T.R., Rock J.A., Meyer-Bahlburg H.F., Money J., et al. 46,XY intersex individuals: phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. Pediatrics 110 (2002) e32
94. Skuse D.H., James R.S., Bishop D.V.M., Coppin B., Dalton P., Aamodt-Leeper G., et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387 (1997) 705-708
95. Thomas G.M., Dembo A.J., Hacker N.F., and DePetrillo A.D. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 70 (1987) 268-275
96. Williams S.D., Blessing J.A., Hatch K.D., and Homesley H.D. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. J Clin Oncol 9 (1991) 1950-1955
97. Lam C., and Harding S. Abdomino-pelvic mass and positive pregnancy test in an XY female. Aust N Z J Obstet Gynaecol 42 (2002) 312-314
98. Bondestam K. Creation of a vagina by sexual intercourse in woman with vaginal agenesis. Lakartidningen 101 (2004) 3717-3718
99. Borruto F., Camoglio F.S., Zampieri N., and Fedele L. The laparoscopic Vecchietti technique for vaginal agenesis. Int J Gynaecol Obstet 98 (2007) 15-19
100. Frost-Arner L., Aberg M., and Janson P.O. Current plastic surgery in abnormalities of female genitalia. Larkartidningen 101 (2004) 2894-2898
101. Newman K., Randolph J., and Anderson K. The surgical management of infants and children with ambiguous genitalia. Lessons learned from 25 years. Ann Surg 215 (1992) 644-653